AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 1 filers reported holding AKCEA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $98,954 | +47.0% | 5,455 | +11.1% | 0.00% | +100.0% |
| Q2 2020 | $67,294 | -4.2% | 4,912 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $70,242 | -17.2% | 4,912 | -1.9% | 0.00% | 0.0% |
| Q4 2019 | $84,836 | +10.1% | 5,008 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $77,073 | -34.4% | 5,008 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $117,438 | -17.2% | 5,008 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $141,877 | -6.0% | 5,008 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $150,941 | -13.9% | 5,008 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $175,380 | -99.9% | 5,008 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $128,255,000 | +130772.4% | 5,008 | -10.9% | 0.00% | +100.0% |
| Q4 2017 | $98,000 | -78.6% | 5,618 | -66.0% | 0.00% | -66.7% |
| Q3 2017 | $457,000 | – | 16,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,389,571 | $61,197,000 | 1.69% |
| Virtus ETF Advisers LLC | 39,351 | $1,008,000 | 0.88% |
| Eventide Asset Management | 175,000 | $4,482,000 | 0.21% |
| ALTRINSIC GLOBAL ADVISORS LLC | 187,800 | $4,810,000 | 0.19% |
| Bellevue Group AG | 48,799 | $1,250,000 | 0.12% |
| Perceptive Advisors | 97,144 | $2,488,000 | 0.07% |
| FMR LLC | 10,008,016 | $256,306,000 | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 3,384,101 | $86,667,000 | 0.02% |
| Virtu Financial LLC | 12,571 | $322,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 7,843 | $201,000 | 0.01% |